CEO / President
Ron Ellis is one of the founders of Endocyte and has served as president and chief executive officer since January 1996, and as a member of our board of directors since December 1995.
Prior to joining Endocyte, Mr Ellis was with Hill-Rom Company, the $1.2 billion healthcare division of Hillenbrand Industries. While at Hill-Rom, he held a variety of senior management positions, including vice president of strategy/corporate development and vice president of the specialty care division. Mr Ellis holds a B.S. in computer science, an M.B.A. from Brigham Young University and a certification in regulatory affairs from Purdue University.